Literature DB >> 10382875

Bactericidal properties of moxifloxacin and post-antibiotic effect.

F J Boswell1, J M Andrews, R Wise, A Dalhoff.   

Abstract

The time-kill kinetics and post-antibiotic effect (PAE) of moxifloxacin were studied for strains of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Staphylococcus aureus and Escherichia coli. Moxifloxacin had a bactericidal effect against all strains tested, with the least rapid bactericidal effect being against S. pyogenes and the most rapid effect against S. aureus and E. coli. The PAE of moxifloxacin was similar to that of other fluoroquinolones and increased with increasing concentration. No association was found between the bactericidal effect of moxifloxacin and the duration of PAE. Gram-positive and gram-negative organisms were also exposed to concentrations of moxifloxacin, sparfloxacin and amoxycillin that simulated the drug concentrations obtained in human serum after standard oral dosing schedules. Simulation of moxifloxacin concentrations in human serum reduced viable counts more effectively and more rapidly than shown in time-kill experiments; in contrast, sparfloxacin and amoxycillin were less effective than when constant concentrations of these antibacterials were used.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382875     DOI: 10.1093/jac/43.suppl_2.43

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Comparative killing rates of fluoroquinolones and cell wall-active agents.

Authors:  J C Fung-Tomc; E Gradelski; L Valera; B Kolek; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.

Authors:  Roland R Regoes; Camilla Wiuff; Renata M Zappala; Kim N Garner; Fernando Baquero; Bruce R Levin
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.

Authors:  Kevin M Watt; Matthew M Massaro; Brian Smith; Michael Cohen-Wolkowiez; Daniel K Benjamin; Matthew M Laughon
Journal:  Pediatr Infect Dis J       Date:  2012-02       Impact factor: 2.129

4.  Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model.

Authors:  Delphine Paillard; Jean Grellet; Véronique Dubois; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Reactive Oxygen Species Production Is a Major Factor Directing the Postantibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.

Authors:  M T García; M V Valenzuela; M J Ferrándiz; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 6.  Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.

Authors:  J A Balfour; H M Lamb
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 7.  Moxifloxacin in uncomplicated skin and skin structure infections.

Authors:  Richard B R Muijsers; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 8.  Moxifloxacin: a review of its use in the management of bacterial infections.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis.

Authors:  Solène Grayo; Marie-Catherine Lott-Desroches; Olivier Dussurget; Renaud Respaud; Arnaud Fontanet; Olivier Join-Lambert; Eric Singlas; Alban Le Monnier
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

10.  Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.

Authors:  Esra Guzeldemir-Akcakanat; Cem-Abdulkadir Gurgan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.